Reynolds TC - Search Results

1

Protecting the privacy of third-party information: recommendations for social and behavioral health researchers.

Lounsbury DW, Reynolds TC, Rapkin BD, Robson ME, Ostroff J. Lounsbury DW, et al. Among authors: reynolds tc. Soc Sci Med. 2007 Jan;64(1):213-22. doi: 10.1016/j.socscimed.2006.08.035. Epub 2006 Oct 17. Soc Sci Med. 2007. PMID: 17049702

2

Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.

Arora K, Tran TN, Kemel Y, Mehine M, Liu YL, Nandakumar S, Smith SA, Brannon AR, Ostrovnaya I, Stopsack KH, Razavi P, Safonov A, Rizvi HA, Hellmann MD, Vijai J, Reynolds TC, Fagin JA, Carrot-Zhang J, Offit K, Solit DB, Ladanyi M, Schultz N, Zehir A, Brown CL, Stadler ZK, Chakravarty D, Bandlamudi C, Berger MF. Arora K, et al. Among authors: reynolds tc. Cancer Discov. 2022 Nov 2;12(11):2552-2565. doi: 10.1158/2159-8290.CD-22-0312. Cancer Discov. 2022. PMID: 36048199 Free PMC article.

3

A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.

Chapman WC, Singla N, Genyk Y, McNeil JW, Renkens KL Jr, Reynolds TC, Murphy A, Weaver FA. Chapman WC, et al. Among authors: reynolds tc. J Am Coll Surg. 2007 Aug;205(2):256-65. doi: 10.1016/j.jamcollsurg.2007.03.020. Epub 2007 Jun 27. J Am Coll Surg. 2007. PMID: 17660072 Clinical Trial.

4

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.

Lovejoy AE, Reynolds TC, Visich JE, Butine MD, Young G, Belvedere MA, Blain RC, Pederson SM, Ishak LM, Nugent DJ. Lovejoy AE, et al. Among authors: reynolds tc. Blood. 2006 Jul 1;108(1):57-62. doi: 10.1182/blood-2005-02-0788. Epub 2006 Mar 23. Blood. 2006. PMID: 16556896 Free article. Clinical Trial.

5

Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized, placebo-controlled, double-blind, multi-dose study.

Visich JE, Zuckerman LA, Butine MD, Gunewardena KA, Wild R, Morton KM, Reynolds TC. Visich JE, et al. Among authors: reynolds tc. Thromb Haemost. 2005 Oct;94(4):802-7. doi: 10.1160/TH05-04-0292. Thromb Haemost. 2005. PMID: 16270634 Clinical Trial.

6

Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers.

Reynolds TC, Butine MD, Visich JE, Gunewardena KA, MacMahon M, Pederson S, Bishop PD, Morton KM. Reynolds TC, et al. J Thromb Haemost. 2005 May;3(5):922-8. doi: 10.1111/j.1538-7836.2005.01224.x. J Thromb Haemost. 2005. PMID: 15869585 Free article. Clinical Trial.

7

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.

Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R, Taylor G, Carter BJ, Guggino WB. Flotte TR, et al. Among authors: reynolds tc. Hum Gene Ther. 2003 Jul 20;14(11):1079-88. doi: 10.1089/104303403322124792. Hum Gene Ther. 2003. PMID: 12885347 Clinical Trial.

8

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.

Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P. Wagner JA, et al. Among authors: reynolds tc. Hum Gene Ther. 2002 Jul 20;13(11):1349-59. doi: 10.1089/104303402760128577. Hum Gene Ther. 2002. PMID: 12162817 Clinical Trial.

9

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.

Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC. Aitken ML, et al. Among authors: reynolds tc. Hum Gene Ther. 2001 Oct 10;12(15):1907-16. doi: 10.1089/104303401753153956. Hum Gene Ther. 2001. PMID: 11589832 Clinical Trial.

10

Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer.

Yoo GH, Hung MC, Lopez-Berestein G, LaFollette S, Ensley JF, Carey M, Batson E, Reynolds TC, Murray JL. Yoo GH, et al. Among authors: reynolds tc. Clin Cancer Res. 2001 May;7(5):1237-45. Clin Cancer Res. 2001. PMID: 11350889 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page